Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective randomized double-blind study of corn- versus potato-based hydroxyethyl starch on perioperative blood loss in elective cardiac surgery
2011-005920-16Phase 4Completed
- Sponsor
- CHU Brugmann
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of hetastarch (2 arms), sponsored by CHU Brugmann. Primary endpoint: Perioperative blood loss. Started Jan 2012; status: completed.
02
Drugs
hetastarch
Beyond the preview
Go deeper on 2011-005920-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005920-16.